MoneyWorks4Me

Indrayani Biotech - Quaterly Results

30 May 2024 Evaluate
The sales slipped to Rs. 157.99 millions for the March 2024 quarter as against Rs. 213.05 millions during the year-ago period.The company suffered a huge decline of -91.74% to Rs. 0.72  millions from Rs. 8.72 millions  of corresponding previous quarter.Operating profit for the quarter ended March 2024 rose to 44.51 millions as compared to 25.98 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 157.99 213.05 -25.84 623.23 744.80 -16.32 623.23 744.80 -16.32
Other Income 34.46 1.53 2152.29 36.19 6.42 463.71 36.19 6.42 463.71
PBIDT 44.51 25.98 71.32 92.84 92.96 -0.13 92.84 92.96 -0.13
Interest 24.72 12.43 98.87 48.28 27.84 73.42 48.28 27.84 73.42
PBDT 19.79 13.55 46.05 44.56 65.12 -31.57 44.56 65.12 -31.57
Depreciation 3.55 4.83 -26.50 14.48 9.33 55.20 14.48 9.33 55.20
PBT 16.24 8.72 86.24 30.08 55.79 -46.08 30.08 55.79 -46.08
TAX 15.52 0.00 0.00 15.52 0.22 6954.55 15.52 0.22 6954.55
Deferred Tax 10.10 0.00 0.00 10.10 0.00 0.00 10.10 0.00 0.00
PAT 0.72 8.72 -91.74 14.56 55.57 -73.80 14.56 55.57 -73.80
Equity 455.36 342.27 33.04 455.36 342.27 33.04 455.36 342.27 33.04
PBIDTM(%) 28.17 12.19 131.03 14.90 12.48 19.35 14.90 12.48 19.35
Peers
Company Name CMP
Grasim Industries 3188.00
DCM Shriram 984.20
3M India 34722.30
Hindustan Foods 617.45
Balmer Lawrie & Co 166.15
View more..